Author

Ingrid Ordás

CHARACTERISTICS AND MANAGEMENT OF PYODERMA GANGRENOSUM AND ERYTHEMA NODOSUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PIONOSO MULTICENTER STUDY
CHARACTERISTICS AND MANAGEMENT OF PYODERMA GANGRENOSUM AND ERYTHEMA NODOSUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PIONOSO MULTICENTER STUDY

Ingrid Ordás  et al.

DISAGREEMENT BETWEEN ENDOSCOPIC AND TRANSMURAL HEALING IN CROHN’S DISEASE AND THE IMPACT OF DISEASE DURATION
DISAGREEMENT BETWEEN ENDOSCOPIC AND TRANSMURAL HEALING IN CROHN’S DISEASE AND THE IMPACT OF DISEASE DURATION

Ingrid Ordás  et al.

ENDOSCOPIC STRICTUROTOMY VERSUS ENDOSCOPIC BALLOON DILATION FOR THE TREATMENT OF INTESTINAL STRICTURES IN CROHN'S DISEASE
ENDOSCOPIC STRICTUROTOMY VERSUS ENDOSCOPIC BALLOON DILATION FOR THE TREATMENT OF INTESTINAL STRICTURES IN CROHN'S DISEASE

Ingrid Ordás  et al.

SAFETY AND EFFICACY OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY CROHN’S DISEASE AFTER CYCLOPHOSPHAMIDE-FREE MOBILIZATION: PRELIMINARY RESULTS
SAFETY AND EFFICACY OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY CROHN’S DISEASE AFTER CYCLOPHOSPHAMIDE-FREE MOBILIZATION: PRELIMINARY RESULTS

Ingrid Ordás  et al.

SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB THERAPY IN CLINICAL PRACTICE: EFFICACY AND SAFETY IN INFLAMMATORY BOWEL DISEASE
SWITCH FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB THERAPY IN CLINICAL PRACTICE: EFFICACY AND SAFETY IN INFLAMMATORY BOWEL DISEASE

Ingrid Ordás  et al.

REAL-LIFE EXPERIENCE OF THE EFFICACY, SAFETY AND PHARMACOKINETIC DATA OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INACTIVE INFLAMMATORY BOWEL DISEASE PATIENTS. RESULTS FROM THE ENEIDA REGISTRY
REAL-LIFE EXPERIENCE OF THE EFFICACY, SAFETY AND PHARMACOKINETIC DATA OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INACTIVE INFLAMMATORY BOWEL DISEASE PATIENTS. RESULTS FROM THE ENEIDA REGISTRY

Ingrid Ordás  et al.

Item 1 - 6 / 6
1